Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | GFER | P55789 | 1/20 | 0.37 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | TOP2A | P11388 | 1/20 | 0.36 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.36 |
| ▸ | LTK | P29376 | 1/20 | 0.36 |
| ▸ | MST1R | Q04912 | 1/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.36 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.36 |
| ▸ | CDK1 | P06493 | 1/20 | 0.36 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11904077 | 0.90 | DPP4 (0.38) | KDM4EALDH1A1GAAGFERCYP19A1 | |
| SCHEMBL2498595 | 0.75 | CYP17A1 (0.38) | TGFBR1CYP2A6CYP17A1RAB9A | |
| SCHEMBL1033845 | 0.75 | NPC1 (0.43) | KDM4EALDH1A1GAAGFERCYP3A4 | |
| SCHEMBL1023476 | 0.74 | RPS6KB2 (0.37) | KDM4EALDH1A1GAACYP19A1CDK5 | |
| SCHEMBL28083058 | 0.71 | TOP2A (0.49) | KDM4EALDH1A1GAAGFERCCNA2 | |
| SCHEMBL2493981 | 0.71 | KDM4E (0.41) | KDM4EALDH1A1GAAGFERCCNA2 | |
| SCHEMBL3358739 | 0.67 | TOP2A (0.59) | KDM4EALDH1A1GAAGFERCCNA2 | |
| SCHEMBL1023046 | 0.67 | ADORA2A (0.51) | KDM4EALDH1A1GAACDK5CDK5R1 | |
| SCHEMBL28755209 | 0.66 | CDK5 (0.45) | KDM4EALDH1A1GAAGFERCCNA2 | |
| SCHEMBL2495572 | 0.66 | KDM4E (0.50) | KDM4EALDH1A1GAAGFERCCNA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024111671-A1 | NUCLEIC ACID APTAMER | ゼノリス プライベート リミテッド | 2024-05-30 | — | — | WO | claimed |
| EP-3369820-B1 | DNA APTAMER CAPABLE OF BONDING TO VWF | TAGCYX BIOTECHNOLOGIES INC (JP) | 2021-12-08 | — | — | EP | claimed |
| EP-3918091-A1 | METHOD OF SEQUENCING NUCLEIC ACID WITH UNNATURAL BASE PAIRS | Agency for Science, Technology and Research (SG) | 2021-12-08 | — | — | EP | claimed |
| EP-3266871-B1 | METHOD FOR STABILIZING DNA APTAMERS | TAGCYX BIOTECHNOLOGIES INC (JP) | 2021-04-28 | — | — | EP | claimed |
| EP-3369819-B1 | DNA APTAMER BINDING TO CANCER CELL | AGENCY SCIENCE TECH & RES (SG) | 2020-11-18 | — | — | EP | claimed |
| US-10837964-B2 | DNA aptamer binding to cancer cell | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-11-17 | — | — | US | claimed |
| US-10760083-B2 | DNA aptamer that binds to vWF | TAGCYX BIOTECHNOLOGIES INC. (JP) | 2020-09-01 | — | — | US | claimed |
| WO-2020159435-A1 | METHOD OF SEQUENCING NUCLEIC ACID WITH UNNATURAL BASE PAIRS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-08-06 | — | — | WO | claimed |
| US-10550393-B2 | Method for stabilizing DNA aptamers | TAGCYX BIOTECHNOLOGIES (JP) | 2020-02-04 | — | — | US | claimed |
| US-20190345499-A1 | METHOD FOR STABILIZING DNA APTAMERS | TAGCYX BIOTECHNOLOGIES (JP) | 2019-11-14 | — | — | US | claimed |
| US-20130122506-A1 | NUCLEIC ACID BASE ANALOGS WITH QUENCHING AND FLUORESCENT ACTIVITIES AND APPLICATIONS THEREOF | TAGCYX BIOTECHNOLOGIES C/O RIKEN (JP) | 2013-05-16 | — | — | US | claimed |
| EP-2562255-A1 | NUCLEIC ACID BASE ANALOG WITH QUENCHING CHARACTERISTICS AND FLUORESCENCE AND APPLICATION THEREOF | Riken (JP) | 2013-02-27 | — | — | EP | claimed |
| EP-1970445-B1 | METHOD FOR NUCLEIC ACID REPLICATION AND NOVEL ARTIFICIAL BASE PAIRS | RIKEN (JP) | 2012-09-26 | — | — | EP | claimed |
| US-20120231462-A1 | ARTIFICIAL BASE PAIR CAPABLE OF FORMING SPECIFIC BASE PAIR | TAGCYX BIOTECHNOLOGIES (JP) | 2012-09-13 | — | — | US | claimed |
| EP-2487181-A1 | ARTIFICIAL BASE PAIR CAPABLE OF FORMING SPECIFIC BASE PAIR | Riken (JP) | 2012-08-15 | — | — | EP | claimed |
| US-8030478-B2 | Method for nucleic acid replication and novel artificial base pairs | RIKEN (JP) | 2011-10-04 | — | — | US | claimed |
| US-20100323364-A1 | MODIFIED tRNA CONTAINING UNNATURAL BASE AND USE THEREOF | THE UNIVERSITY OF TOKYO (JP) | 2010-12-23 | — | — | US | claimed |
| EP-2246428-A1 | MODIFIED TRNA CONTAINING NON-NATURAL NUCLEOTIDE AND USE THEREOF | The University of Tokyo (JP) | 2010-11-03 | — | — | EP | claimed |
| US-20100036111-A1 | METHOD FOR REPLICATING NUCLEIC ACIDS AND NOVEL UNNATURAL BASE PAIRS | RIKEN (JP) | 2010-02-11 | — | — | US | claimed |
| EP-1970445-A1 | METHOD FOR NUCLEIC ACID REPLICATION AND NOVEL ARTIFICIAL BASE PAIRS | Riken (JP) | 2008-09-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100036111-A1 | METHOD FOR REPLICATING NUCLEIC ACIDS AND NOVEL UNNATURAL BASE PAIRS | POLM, POLL, POLRMT | KDM4E 1933/4885ALDH1A1 2586/4885GAA 1766/4885 |
| US-20120231462-A1 | ARTIFICIAL BASE PAIR CAPABLE OF FORMING SPECIFIC BASE PAIR | NSUN2, EIF2AK2, NSUN3 | KDM4E 3694/4885ALDH1A1 1963/4885GAA 1909/4885 |
| US-20100323364-A1 | MODIFIED tRNA CONTAINING UNNATURAL BASE AND USE THEREOF | TRMT1, NSUN3, TARBP1 | KDM4E 2184/4885ALDH1A1 3848/4885GAA 1214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.